VYSIS UROVYSION BLADDER CANCER RECURRENCE KIT
FDA 510(k) clearance K011031 · decided 2001-08-03
Clearance details
- K-number
- K011031
- Device name
- VYSIS UROVYSION BLADDER CANCER RECURRENCE KIT
- Applicant
- Vysis
- Decision
- Substantially Equivalent
- Date received
- 2001-04-05
- Decision date
- 2001-08-03
- Days to decision
- 120 days
- Clearance type
- Traditional
- Product code
- MMW
- Device class
- 2
- Regulation number
- 866.6010
- Medical specialty
- Immunology
- Advisory committee
- Immunology
- Location
- Downers Grove, IL, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Vysis
The Builder collects up to 8 candidate devices side by side with yours, then exports the substantial-equivalence comparison scaffold. How it works
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
| Record | Firm | Date |
|---|---|---|
| Bladder EpiCheck DNA extraction kit, NX899090-01C, Bladder EpiCheck test kit, NX899090-02C, Bladder EpiCheck Software, NX899090-03C (K203245) | Nucleix , Ltd. | 2023-05-04 |
| MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST (K033982) | Vysis | 2004-01-22 |
| NMP22 BLADDERCHEK KIT, NMP22 CONTROL KIT (K021231) | Matritech, Inc. | 2002-07-30 |
| UROVYSION BLADDER CANCER RECURRENCE KIT (K013785) | Vysis | 2002-02-08 |
| BTA STAT TEST PRESCRIPTION HOME USE (K974845) | Bard Diagnostic Sciences,Inc. | 1998-12-08 |
| BARD BTA TRAK TEST (K971402) | Bard Diagnostic Sciences,Inc. | 1998-04-15 |
| AURA TEK FDP (K970353) | Perimmune, Inc. | 1997-04-30 |
| BARD AND BTA TEST (K964151) | Bard Diagnostic Sciences,Inc. | 1997-04-16 |
Recalls involving this device
| Record | Firm | Date |
|---|---|---|
| ProbeChek Vysis UroVysion Control Slides, for Fluorescence in situ Hybridization (FISH) us recall (Z-0640-04) | Vysis | 2004-07-20 |